Skip to content

Agfa Healthcare Corp.

US Last updated 23 May 2026

Devices
17
Registries
GUDIDFDA 510(k)FDA
FDA recalls
153 ongoing

Catalogue17

FDA recalls15

Recalls this firm reported to the FDA. Device pages show the recalls that name the device or the 510(k)/PMA it was cleared under.

Showing the 10 most recent of 15 recalls.

  • 2025

    • 18 Nov 2025 Z-0923-2026 Class II Ongoing It is possible to exceed the maximum allowed Air Kerma rate (AKR) of 88mGy/min for pulsed fluoro exams. This can happen in case the framerate is increased on the NX workstation when ABS is not enabled.via FDA establishment Agfa HealthCare GmbH
  • 2024

    • 6 Sep 2024 Z-0055-2025 Class II Ongoing Software defect, when an image has non-square pixel spacing, the reference/localizer line is incorrectly placed on the scout image in the XERO Viewet, may display the incorrect crosshair/line position on the non-coplanar/scout image with respect to the axial slice location. Inaccurate placement of reference lines or crosshairs have potential risk of misdiagnosis or mistreatment due to unintended shifts in the display of anatomical locations.via FDA establishment Agfa HealthCare GmbH
  • 2022

    • 5 Dec 2022 Z-1004-2023 Class II Ongoing There is a software defect that can cause issues with images.via FDA establishment Agfa HealthCare GmbH
  • 2018

    • 3 Aug 2018 Z-0101-2019 Class II Terminated Adding an additional comparison study to the Clinical Side Bar in the Enterprise Imaging Diagnostics Desktop, can result in a change of the sort order of the studies in the Clinical Side Bar. The thumbnail images of the studies are no longer chronologically sorted with the most recent study at the top.via FDA establishment Agfa HealthCare GmbH
  • 2016

    • 22 Dec 2016 Z-2652-2017 Class II Terminated A customer experienced when using IMPAX CV Reporting software, specifically, when building a NIV report, the NIV Cardio report was showing incorrect findings for Aneurysm.via FDA establishment Agfa HealthCare GmbH
    • 21 Dec 2016 Z-2735-2017 Class II Terminated A customer reported that when using an NX workstation with software version NX 3.0.8950 software and selecting the affected patient/exam from closed exams, initially the wrong image was linked to the exam and appeared. After a short time the wrong image was replaced by the correct image, however the wrong image was used for transmitting to PACS.via FDA establishment Agfa HealthCare GmbH
    • 2 May 2016 Z-1738-2017 Class II Terminated One of the dent markers from the DX-D600 dropped down from the overhead rail.via FDA establishment Agfa HealthCare GmbH
    • 20 Jan 2016 Z-1698-2017 Class II Terminated The DX-D100 User Manual already contained information about to move a DX-D100 mobile unit manually by using an Allen wrench, but did not indicate where the Allen wrench should be stored.via FDA establishment Agfa HealthCare GmbH
  • 2015

    • 1 Sep 2015 Z-0283-2016 Class II Terminated Customers have experienced IMPAX CV software, specifically, Demographics Manager (DM), not producing correct pdf reports after the reports, at the time of physician signature, were correct.via FDA establishment Agfa HealthCare GmbH
    • 26 Jun 2015 Z-2061-2015 Class II Terminated Firm received a complaint that the hospital had sent two accession numbers over the same morning and on the Agility side the patient name was incorrect.via FDA establishment Agfa HealthCare GmbH
Show all 15 recalls
  • 2015

    • 29 May 2015 Z-1745-2015 Class II Terminated When using the DX-D 100 unit, sporadic unintended movements caused by an electrostatic discharge of the unit to the ground may occur.via FDA establishment Agfa HealthCare GmbH
  • 2014

    • 24 Oct 2014 Z-0804-2015 Class III Terminated Some material of the coating Type CXCPMV3 has potential artifacts showing a small bright thin line when the film is processed.via FDA establishment Agfa HealthCare GmbH
    • 16 Jul 2014 Z-2178-2014 Class III Terminated Some sheets of the medical screen film are fogged.via FDA establishment Agfa HealthCare GmbH
    • 2 Jul 2014 Z-2175-2014 Class II Terminated Some customers reported that while using the DX-D600 in room or exam preparation, the Overhead Tube Crane (OTC) showed increased velocity and uncontrolled longitudinal movement.via FDA establishment Agfa HealthCare GmbH
    • 13 May 2014 Z-2176-2014 Class III Terminated Unit was mislabeled with a factory label showing 32 KW output power.via FDA establishment Agfa HealthCare GmbH

FDA establishments3

Registered with the FDA under this company group, matched by name.

  • Agfa Healthcare Inc. WATERLOO Ontario · CA FEI 3008794078
  • Agfa HealthCare GmbH Vienna Wien · AT FEI 3009238185
  • Agfa HealthCare NV Gent West-Vlaanderen · BE FEI 3009238175

What Agfa Healthcare Corp. makes

Agfa Healthcare Corp. develops and provides radiological Picture Archiving and Communication Systems (PACS) software, including IMPAX and its clinical applications, as well as PACS workstation solutions like the IMPAX SE SIGMACOM client. Their portfolio also includes computed radiography systems paired with NX2.X workstations and specialized orthopedic software designed for IMPAX workstations.

The company’s products are classified under FDA’s Class II regulatory category and are listed under the 510(k) and Unique Device Identification (UDI) registries. These devices are regulated under US jurisdiction, where Agfa Healthcare Corp. is based.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Agfa Healthcare Corp. primarily manufacture?

Agfa Healthcare Corp. specializes in radiological Picture Archiving and Communication Systems (PACS) software. Their portfolio includes software solutions like IMPAX and its clinical applications, PACS workstation tools such as the IMPAX SE SIGMACOM client, computed radiography systems paired with NX2.X workstations, and specialized orthopedic software designed for IMPAX workstations. These products focus on digital imaging and data management in radiology workflows.

Where is Agfa Healthcare Corp. based, and how does this affect their device regulations?

Agfa Healthcare Corp. is based in the United States, which means their devices fall under FDA jurisdiction. Since they develop radiological PACS software and related systems, these products are classified under the FDA’s Class II regulatory category, indicating a moderate level of risk that requires compliance with specific regulatory controls. Their devices are also listed in the FDA’s 510(k) and Unique Device Identification (UDI) registries, reflecting their regulatory oversight.

Which regulatory registries list Agfa Healthcare Corp.’s devices, and why are these important?

Agfa Healthcare Corp.’s devices are listed in the FDA’s 510(k) and Unique Device Identification (UDI) registries. The 510(k) process demonstrates that a device is substantially equivalent to a legally marketed predicate device, ensuring it meets safety and effectiveness standards. The UDI system provides a unique identifier for each device, improving tracking, traceability, and transparency in the healthcare supply chain, which is critical for patient safety and regulatory compliance.

How are Agfa Healthcare Corp.’s devices classified by the FDA, and what does this classification imply?

Agfa Healthcare Corp.’s devices are classified under the FDA’s Class II category. This classification indicates that while the devices pose a moderate risk, they are not low-risk (Class I) or high-risk (Class III). As a result, they require special controls beyond general controls to ensure their safety and performance, such as performance standards, post-market surveillance, or labeling requirements. The classification ensures that these radiological PACS and related systems meet rigorous regulatory standards before entering the market.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
US